Ventyx Biosciences (VTYX) Revenue & Revenue Breakdown
Ventyx Biosciences Revenue Highlights
00
Ventyx Biosciences Revenue by Period
Ventyx Biosciences Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
Ventyx Biosciences Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $1.08M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | - |
Ventyx Biosciences Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
UTHR | United Therapeutics | $2.33B | $748.90M |
ASND | Ascendis Pharma | $266.72M | $95.89M |
IMCR | Immunocore | $249.43M | $75.40M |
TVTX | Travere Therapeutics | $145.24M | $62.90M |
ACLX | Arcellx | $110.32M | $26.03M |
PTGX | Protagonist Therapeutics | $60.00M | $4.67M |
IDYA | IDEAYA Biosciences | $23.39M | - |
GPCR | Structure Therapeutics | - | - |
PCVX | Vaxcyte | - | - |
NUVL | Nuvalent | - | - |
DICE | DICE Therapeutics | - | - |
VRNA | Verona Pharma | - | $5.62M |
CERE | Cerevel Therapeutics | - | - |
REPL | Replimune Group | - | - |
SNDX | Syndax Pharmaceuticals | - | $12.50M |
VTYX | Ventyx Biosciences | - | - |